Dark title card reading How nicotine pouches actually work beside three stacked white pouches

How nicotine pouches actually work

Posted on

A nicotine pouch works by holding nicotine against the inside of your lip in a chemical form that can cross the mucous membrane. An alkaline buffer converts much of the nicotine to its uncharged free-base form, which passes through the lining of the mouth into the bloodstream directly, bypassing the liver. Peak blood levels arrive in roughly 20 to 65 minutes.

That last number is the one that matters most, and it is the reason a pouch feels so different from a cigarette even at comparable doses. A cigarette peaks in five to eight minutes. A pouch takes four to ten times longer to get there. Everything else — the filler, the pH, the flavour, the number printed on the tin — is detail hung off that basic fact.

What is actually inside a pouch

Germany’s Federal Institute for Risk Assessment, a national regulator, gives the shortest accurate answer: “nicotine salts are used, which are mixed with microcrystalline cellulose, various salts (sodium carbonate and hydrogen carbonate), citric acid and aromas” (BfR Opinion 027/2021).

FDA’s own review of the ZYN applications describes the same thing in regulatory language: “pouched oral tobacco products containing tobacco-derived nicotine, flavor ingredients, an artificial sweetener, stabilizers, fillers, and pH adjusters”. The specific identities of the sweetener and humectant are redacted in the public version of that document, so nobody outside FDA and the manufacturer can tell you exactly which ones ZYN uses.

An independent laboratory analysis of 30 pouches across 14 brands found pouch weights from 368.6 to 663.3 mg, total nicotine from 2.10 to 20.83 mg/g, humectants (propylene glycol or glycerol) in 23 of 30 samples, and water in all of them, from 17.15 to 391.02 mg/g (Han et al., Microchemical Journal, 2025).

The cellulose does nothing pharmacologically. It is scaffolding — it holds the shape and keeps the contents where you put them.

Why pH is the whole trick

Nicotine is a weak base. In acidic conditions it carries a charge; in alkaline conditions it does not. Only the uncharged form crosses a cell membrane easily.

The Surgeon General’s report states it directly: “At a high (alkaline) pH, nicotine is in the nonionized state, which is associated with the ability to more easily pass through lipoprotein membranes” (How Tobacco Smoke Causes Disease). IARC describes the deliberate use of this in oral products: “Ammonia, ammonium carbonate and sodium carbonate are applied to control nicotine delivery by raising pH and subsequently the level of unprotonated nicotine which is most readily absorbed through the mouth into the bloodstream” (IARC Monographs Vol. 100E).

So the sodium carbonate in the ingredient list is not a filler or a preservative. It is the active engineering decision in the product.

How much difference does it make? A CDC laboratory study measured 37 pouch products from six manufacturers and found pH ranging from 6.86 to 10.1, and free nicotine ranging from 7.7% to 99.2% of the total (Stanfill et al., Nicotine & Tobacco Research, 2021). Germany’s BfR found a median pH of 8.8 and a median free-base proportion of 86% across the products it assessed.

Two pouches labelled 6 mg, one at pH 7 and one at pH 9.4, are not the same product. I would treat the mg figure as a ceiling rather than a dose.

How the nicotine reaches your blood

From the mucous membrane the nicotine enters the venous circulation of the head and neck, and from there the general circulation — without first passing through the liver. That is the key structural difference from swallowing it. The Surgeon General’s report: “unlike when it is swallowed, nicotine’s bioavailability is greater through the lung or through the oral mucosa because nicotine reaches systemic circulation before passing through the liver (first-pass metabolism).”

Some of the nicotine is inevitably swallowed with saliva. That fraction goes through the liver and most of it does not survive the trip, which is why swallowing hard on a pouch wastes it rather than intensifying it.

The contrast with smoking is anatomical, not chemical. Inhaled nicotine crosses the vast surface of the alveoli into arterial blood and reaches the brain “in about 10 to 19 seconds”, producing “both the highest peak concentration and most rapid rate of nicotine absorption” of any route studied. Nothing placed under a lip can do that, and no formulation change would alter it.

How fast, and how much: the numbers

Here is what has actually been measured. Read the funding column — it is not decoration.

Product Peak level (Cmax) Time to peak (Tmax) Study Funding
Nicotine pouch, 3 mg 7.7 ng/mL 61 min Lunell 2020 Swedish Match
Nicotine pouch, 6 mg 14.7 ng/mL 66 min Lunell 2020 Swedish Match
Nicotine pouch, 8 mg 18.5 ng/mL 59 min Lunell 2020 Swedish Match
Swedish snus, 8 mg 10.6 ng/mL 69 min Lunell 2020 Swedish Match
American moist snuff, 18 mg 16.9 ng/mL 65 min Lunell 2020 Swedish Match
Nicotine pouch 8.5 ng/mL 60 min Azzopardi 2022 Imperial Tobacco / BAT
Nicotine lozenge (NRT) 8.3 ng/mL 60 min Azzopardi 2022 Imperial Tobacco / BAT
Nicotine gum (NRT) 4.4 ng/mL 50 min Azzopardi 2022 Imperial Tobacco / BAT
Nicotine pouch 27.9 ng/mL 30 min Przulj 2025 Independent
Cigarette 19.5 ng/mL 6 min Przulj 2025 Independent

The independently funded head-to-head trial is the most interesting row. Przulj and colleagues found pouches produced a higher peak than cigarettes (27.9 against 19.5 ng/mL) but took five times as long to reach it, with levels reaching 13 ng/mL within 10 minutes (Psychopharmacology, 2025). Participants rated the pouches as “delivering more nicotine and being less pleasant than cigarettes; but as effective and as fast in reducing urges to smoke.”

A 2025 systematic review pooling this literature found 4 mg pouches delivered 91.73% of a cigarette’s total exposure but only 69.15% of its peak, with pouch Tmax of 20 to 65 minutes against 5 to 8 minutes for cigarettes (Heshmati et al., Drug and Alcohol Dependence Reports, 2025). The same review notes that “most of included studies were funded by the tobacco industry” — which is a fair description of the evidence base as a whole, and worth carrying in your head whenever you read a number from it.

The number on the tin is not the dose

The labelled milligrams describe what went into the pouch, not what comes out of it.

BfR states that “pharmacokinetic studies show that at least half of the nicotine in the pouch can be absorbed”. A peer-reviewed risk assessment with no declared competing interests puts the extraction rate “between 50 % and 60 % of the total nicotine content”, rising to “62 % of total nicotine content” after 60 minutes, and cites a study finding only “24–52 %” after 20 minutes (Reimann et al., Toxicology Reports, 2024).

Direct measurement of spent product — done on snus and gum rather than pouches, so treat it as context — found extraction varied enormously between individuals: around 31% of total nicotine from pouched snus, with a standard deviation wide enough to swallow the mean (Digard et al., Nicotine & Tobacco Research, 2013, funded by British American Tobacco). How long you keep it in, how much you salivate and how much you swallow all move the figure.

There is a striking footnote in FDA’s own ZYN review: product samples used in one pharmacokinetic study “contained less nicotine than the stated target specification”, and FDA’s chemistry reviewers recommended that the agency “independently verify nicotine content and pH”. If the regulator felt the need to check the label, so should you.

Why a strong pouch hits a new user hard

Nicotine tolerance is real and it builds fast, which means the same pouch is a very different experience for a daily smoker and for someone with no recent exposure.

The independently funded trial above recorded it under controlled conditions: “Three participants who were light smokers experienced nausea and one vomited.” One reported nausea, dizziness and hiccups within three minutes.

BfR lists the effects at the milder end as “nausea and vomiting, with higher exposure symptoms such as diarrhoea, increased salivation and slow heartbeat”, and identifies “children, adolescents and non-smokers” as being at particular risk, citing rapid absorption. A published case report describes a 21-year-old non-smoker with limited prior nicotine exposure who used 15 extra-strength pouches over 12 hours and presented with “nausea, somnolence, and diaphoresis”, confusion and tremor, with blood pressure of 184/99 (Kent et al., Nicotine & Tobacco Research, 2025).

If you are coming to these without a nicotine habit already in place, the honest advice is that you should not be coming to them at all. If you are switching from something else, starting at the bottom of the range costs you nothing. The strengths guide covers where the bands actually sit.

What “FDA authorised” does and does not mean

On 16 January 2025 FDA granted marketing orders to 20 ZYN products. The agency’s own framing is unambiguous, and I will quote it rather than summarise it:

“While today’s actions permit these specific tobacco products to be legally marketed in the U.S. to adults 21 and older, it does not mean these tobacco products are safe, nor are they ‘FDA approved.’ There is no safe tobacco product; youth should not use tobacco products and adults who do not use tobacco products should not start.”

Separately, on 30 June 2026, FDA authorised those same 20 products to carry a specific comparative claim: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” That is a closed list of named diseases, conditional on substitution for cigarettes, and FDA attached to it: “There is no safe tobacco product, and those who do not use tobacco products should not start.”

Neither order says a pouch is safe. Neither says it is a stop-smoking treatment. FDA states that an authorisation of this kind “refers to specific products, not an entire class of tobacco products” — so it says nothing about any other brand on the shelf.

Frequently asked questions

How long should I keep a pouch in? Absorption continues throughout use, and the extraction studies above measure at 20 and 60 minutes, with substantially more nicotine released at 60. There is no single correct duration; longer means more.

Why does it tingle or burn? The alkaline pH that makes the nicotine absorbable is also what you feel. Higher-pH products tend to be more noticeable against the gum.

Does swallowing the saliva increase the effect? No. Swallowed nicotine goes through first-pass liver metabolism and largely does not reach circulation.

Is a pouch equivalent to a cigarette? On total exposure, a 4 mg pouch came to roughly 92% of a cigarette’s in pooled analysis. On speed it is nowhere close — tens of minutes against a handful.

Why is so much of this research industry-funded? Because manufacturers need pharmacokinetic data for regulatory applications and independent funders have been slower to arrive. The studies are not thereby wrong, but the funding is part of the result and should be read with it.

Sources

Nicotine is addictive. No tobacco or nicotine product is safe, and completely stopping is the lowest-risk option. This site is for adults who already use nicotine — 21+ in the United States, 18+ or your local legal age elsewhere. Nothing here is medical advice.